En español
NIDA

ED-Initiated Buprenorphine - Heroes in Practice

Revised September 2018

Emergency physicians around the country have partnered with state entities to develop a spectrum of innovative strategies. These strategies entail increasing access to care, identifying those at high risk for overdose, safe prescribing, offering access to Naloxone, sharing data among agencies, and decreasing stigma by recognizing not only that words matter, but accurate words matter. Some of these heroes are highlighted in the videos below describing what they are doing to combat the opioid epidemic.  See their videos below:

Andrew Herring, MD; Highland Hospital, Oakland California

Gail D’Onofrio MD, MS and Kathryn Hawk MD, MHS; Yale New Haven Hospital, New Haven, CT

Rachel Haroz, MD;  Cooper University Health Care, Camden NJ

Ross Sullivan, MD; Upstate University Hospital, Syracuse NY


Information contained on this webpage is based on NIDA funded research (see Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial). The videos provided above were funded by Aetna, however, all research content featured or discussed in the videos was developed by clinicians from Yale University who have expertise in emergency department settings, with grant funding from NIDA (#5R01DA025991-05) and contract support from NIDA’s Clinical Trials Network These informational resources have been provided as a courtesy on the NIDAMED Web portal, and do not constitute official clinical guidelines or standards, nor do they necessarily represent the official viewpoint and opinion of the NIH or the U.S. Department of Health and Human Services.

This page was last updated September 2018

Get this Publication

    Science to Medicine Series: Medication Treatment for Opioid Use Disorder

    Science to Medicine graphic - a scientist with a microscope and two doctor's talking

    Learn from fellow clinicians in this first topic of the Series

    Get Waivered to Prescribe Buprenorphine